Ocular Therapeutix Inc (OCUL)

8.36 +0.81  +10.73% NASDAQ Jul 15, 16:58 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
08/07/2020 16:30 EDT Misc Ocular Therapeutix Inc Second Quarter Earnings Conference Call in 2020
08/07/2020 Earnings Ocular Therapeutix Inc Second Quarter Earnings in 2020 Release
06/25/2020 08:30 EDT Misc Ocular Therapeutix Inc Annual General Meeting for 2019
05/08/2020 08:30 EDT Misc Ocular Therapeutix Inc First Quarter Earnings Conference Call for 2020
05/08/2020 Earnings Ocular Therapeutix Inc First Quarter Earnings Result for 2020
03/12/2020 16:30 EDT Misc Ocular Therapeutix Inc Fourth Quarter Earnings Conference Call for 2019
03/12/2020 Earnings Ocular Therapeutix Inc Fourth Quarter Earnings in 2019 Release
03/12/2020 Misc Ocular Therapeutix Inc Annual Report for 2019
11/12/2019 08:00 EST Misc Ocular Therapeutix Inc Third Quarter Earnings Conference Call for 2019
11/12/2019 Earnings Ocular Therapeutix Inc Third Quarter Earnings in 2019 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.ocutx.com
  • Investor Relations URL: http://investors.ocutx.com/phoenix.zhtml?c=253650&p=irol-irhome
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Aug. 07, 2020
  • Last Earnings Release: May. 08, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, PTX-TP, and OTX-IVT.

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.